Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Sagimet Biosciences (SGMT) Shares Outstanding (Weighted Average) (2023 - 2024)

Sagimet Biosciences has reported Shares Outstanding (Weighted Average) over the past 2 years, most recently at $31.0 million for Q3 2024.

  • Quarterly results put Shares Outstanding (Weighted Average) at $31.0 million for Q3 2024, up 406.17% from a year ago — trailing twelve months through Sep 2024 was $31.0 million (up 406.17% YoY), and the annual figure for FY2023 was $10.5 million, changed.
  • Shares Outstanding (Weighted Average) for Q3 2024 was $31.0 million at Sagimet Biosciences, down from $31.9 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for SGMT hit a ceiling of $31.9 million in Q2 2024 and a floor of $185137.0 in Q1 2023.